专题报道:芳香化酶抑制剂的临床应用 |
|
|
|
|
芳香化酶抑制剂联合生长激素治疗青春期身材矮小症男性患儿的临床研究 |
孔元梅( ),陈虹,梁黎,郑卯昵,方燕兰,王春林*( ) |
浙江大学医学院附属第一医院儿科, 浙江 杭州 310003 |
|
Aromatase inhibitors combined with growth hormone in treatment of adolescent boys with short stature |
KONG Yuanmei( ),CHEN Hong,LIANG Li,ZHENG Maoni,FANG Yanlan,WANG Chunlin*( ) |
Department of Pediatrics, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China |
引用本文:
孔元梅,陈虹,梁黎,郑卯昵,方燕兰,王春林. 芳香化酶抑制剂联合生长激素治疗青春期身材矮小症男性患儿的临床研究[J]. 浙江大学学报(医学版), 2020, 49(3): 283-290.
KONG Yuanmei,CHEN Hong,LIANG Li,ZHENG Maoni,FANG Yanlan,WANG Chunlin. Aromatase inhibitors combined with growth hormone in treatment of adolescent boys with short stature. J Zhejiang Univ (Med Sci), 2020, 49(3): 283-290.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2020.04.06
或
http://www.zjujournals.com/med/CN/Y2020/V49/I3/283
|
1 |
NAVARRO R , DUNN J D , LEE P A et al. Translating clinical guidelines into practice:the effective and appropriate use of human growth hormone[J]. Am J Manag Care, 2013, 19 (15 Suppl): s281- s289
|
2 |
WIT J M , RANKE M B , ALBERTSSON-WIKLAND K et al. Personalized approach to growth hormone treatment:clinical use of growth prediction models[J]. Horm Res Paediatr, 2013, 79 (5): 257- 270
doi: 10.1159/000351025
|
3 |
HERO M , TOIVIAINEN-SALO S , WICKMAN S et al. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty[J]. J Bone Miner Res, 2010, 25 (7): 1536- 1543
doi: 10.1002/jbmr.56
|
4 |
MAURAS N , GONZALEZ DE PIJEM L , HSIANG H Y et al. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone:a randomized, placebo-controlled, multicenter trial for one to three years[J]. J Clin Endocrinol Metab, 2008, 93 (3): 823- 831
doi: 10.1210/jc.2007-1559
|
5 |
PEDROSA L F , DE OLIVEIRA J M , THOMé P et al. Height increment and laboratory profile of boys treated with aromatase inhibitors with or without growth hormone[J]. Horm Metab Res, 2017, 49 (10): 778- 785
doi: 10.1055/s-0043-116944
|
6 |
MAURAS N , ROSS J L , GAGLIARDI P et al. Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature[J]. J Clin Endocrinol Metab, 2016, 101 (12): 4984- 4993
doi: 10.1210/jc.2016-2891
|
7 |
中华医学会儿科学分会内分泌遗传代谢学组 . 矮身材儿童诊治指南[J]. 中华儿科杂志, 2008, 46 (6): 428- 430 Endocrine Genetic Metabolism Group, Chinese Pediatric Society, Chinese Medical Association . Guidelines for diagnosis and treatment of children with short stature[J]. Chinese Journal of Pediatrics, 2008, 46 (6): 428- 430
|
8 |
王卫平, 孙锟, 常立文 . 儿科学[M]. 9版 北京: 人民卫生出版社, 2018: 66 WANG Weiping , SUN Kun , CHANG Liwen . Pediatrics[M]. 9th Ed Beijing: People's Medical Publishing House, 2018: 66
|
9 |
HERO M , NORJAVAARA E , DUNKEL L . Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature:a randomized controlled trial[J]. J Clin Endocrinol Metab, 2005, 90 (12): 6396- 6402
doi: 10.1210/jc.2005-1392
|
10 |
ROTHENBUHLER A , LINGLART A , BOUGNèRES P . A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature[J]. Int J Pediatr Endocrinol, 2015, 2015 (1): 4
doi: 10.1186/1687-9856-2015-4
|
11 |
李辉, 季成叶, 宗心南 et al. 中国0~18岁儿童、青少年身高、体重的标准化生长曲线[J]. 中华儿科杂志, 2009, 47 (7): 487- 492 H ui , JI Chengye , ZONG Xinnan et al. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years[J]. Chinese Journal of Pediatrics, 2009, 47 (7): 487- 492
doi: 10.3760/cma.j.issn.0578-1310.2009.07.003.LI
|
12 |
WICKMAN S , SAUKKONEN T , DUNKEL L . The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty:a prospective study with a P450-aromatase inhibitor[J]. Eur J Endocrinol, 2002, 146 (3): 339- 346
doi: 10.1530/eje.0.1460339
|
13 |
HERO M , ANKARBERG-LINDGREN C , TASKINEN M R et al. Blockade of oestrogen biosynthesis in peripubertal boys:effects on lipid metabolism, insulin sensitivity, and body composition[J]. Eur J Endocrinol, 2006, 155 (3): 453- 460
doi: 10.1530/eje.1.02226
|
14 |
HERO M , WICKMAN S , HANHIJ?RVI R et al. Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen[J]. J Pediatr, 2005, 146 (2): 245- 252
doi: 10.1016/j.jpeds.2004.09.002
|
15 |
HERO M , MAURY S , LUOTONIEMI E et al. Cognitive effects of aromatase inhibitor therapy in peripubertal boys[J]. Eur J Endocrinol, 2010, 163 (1): 149- 155
doi: 10.1530/EJE-10-0040
|
16 |
WIT J M , HERO M , NUNEZ S B . Aromatase inhibitors in pediatrics[J]. Nat Rev Endocrinol, 2011, 8 (3): 135- 147
doi: 10.1038/nrendo.2011.161
|
17 |
SHULMAN D I, FRANCIS G L, PALMERT M R, et al. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development[J/OL]. Pediatrics, 2008, 121(4): e975-e983. DOI: 10.1542/peds.2007-2081.
|
18 |
T'SJOEN G G , GIAGULLI V A , DELVA H et al. Comparative assessment in young and elderly men of the gonadotropin response to aromatase inhibition[J]. J Clin Endocrinol Metab, 2005, 90 (10): 5717- 5722
doi: 10.1210/jc.2005-0982
|
19 |
SHAMS K , CAMEO T , FENNOY I et al. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress:a retrospective chart review[J]. J Pediatr Endocrinol Metab, 2014, 27 (7-8): 725- 730
doi: 10.1515/jpem-2013-0470
|
20 |
GOUDRIAAN A E , LAPAUW B , RUIGE J et al. The influence of high-normal testosterone levels on risk-taking in healthy males in a 1-week letrozole administration study[J]. Psychoneuro-endocrinology, 2010, 35 (9): 1416- 1421
doi: 10.1016/j.psyneuen.2010.04.005
|
21 |
KIL K E , BIEGON A , DING Y S et al. Synthesis and PET studies of[(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug[J]. Nucl Med Biol, 2009, 36 (2): 215- 223
doi: 10.1016/j.nucmedbio.2008.11.010
|
22 |
SALEHPOUR S , ALIPOUR P , RAZZAGHY-AZAR M et al. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature[J]. Horm Res Paediatr, 2010, 74 (6): 428- 435
doi: 10.1159/000315482
|
23 |
MORRISON J A , SPRECHER D L , BIRO F M et al. Serum testosterone associates with lower high-density lipoprotein cholesterol in black and white males, 10 to 15 years of age, through lowered apolipoprotein AI and AII concentrations[J]. Metabolism, 2002, 51 (4): 432- 437
doi: 10.1053/meta.2002.31321
|
24 |
TAKIUE Y , HOSOYAMADA M , KIMURA M et al. The effect of female hormones upon urate transport systems in the mouse kidney[J]. Nucleos Nucleot Nucl, 2011, 30 (2): 113- 119
doi: 10.1080/15257770.2010.551645
|
25 |
ZENG M , CHEN B , QING Y et al. Estrogen receptor beta signaling induces autophagy and downregulates Glut9 expression[J]. Nucleos Nucleot Nucl, 2014, 33 455- 465
doi: 10.1080/15257770.2014.885045
|
26 |
BUDHIRAJA R , KAYYALI U S , KARAMSETTY M et al. Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism[J]. Antioxid Redox Signal, 2003, 5 (6): 705- 711
doi: 10.1089/152308603770380007
|
27 |
BRYZGALOVA G , GAO H , AHREN B et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice:insulin sensitivity in the liver[J]. Diabetologia, 2006, 49 (3): 588- 597
doi: 10.1007/s00125-005-0105-3
|
28 |
KANBAY M , SEGAL M , AFSAR B et al. The role of uric acid in the pathogenesis of human cardiovascular disease[J]. Heart, 2013, 99 (11): 759- 766
doi: 10.1136/heartjnl-2012-302535
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|